MassBiologics

Boston, MA
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: MassBiologics

Signal Score
63.0/100 (as of 2026-04-02)
Quality Compliance
Assessment pending
Headquarters
Boston, MA
Modalities
AAV, mRNA
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesAAV, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: UMass Chan Medical School
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: UMass Chan Medical School
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Boston, MA
Modalities: AAV, mRNA
Capacity assessment: 58.0/100
Sites: Boston, MA
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Boston, MA
Modalities: AAV, mRNA
Capacity assessment: 58.0/100
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → mRNA CDMOs →

Similar CDMOs

Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
Signal Score: 74.0
Cell Therapy, AAV, mRNA
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Danaher (CGT Portfolio)
Washington, DC
Signal Score: 81.5
Cell Therapy, AAV, mRNA
Lonza
Basel, Switzerland
Signal Score: 78.6
AAV, Lentiviral, Cell Therapy, mRNA
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
Signal Score: 73.8
AAV, Lentiviral, Cell Therapy, mRNA